Q&A: Team Uses Dynamic Proteomics to Study How Multi-Drug Combinations Affect Proteins

A team of researchers from the Weizmann Institute of Science said its approach, which found that protein-drug dynamics in multi-drug combinations can be predicted based on the dynamics in pairs of drugs, could be a way "to bypass the combinatorial explosion problem of research on drug combinations."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.